ArticleAnnals of surgical oncology2026
Current Status and Influencing Factors of Postoperative Sarcopenia in Pancreatic Cancer Patients.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveThis study was designed to investigate the incidence of postoperative sarcopenia in patients with pancreatic cancer and to analyse the related influencing factors.
methodsThis prospective cohort study included 265 pancreatic cancer patients who underwent radical surgery at Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine from September 2023 to January 2024 and determined the incidence of postoperative sarcopenia in pancreatic cancer patients. Multivariate logistic regression analysis was used to identify factors associated with postoperative sarcopenia.
resultsThe incidence of postoperative sarcopenia among 265 pancreatic cancer patients was 46.04%. Multivariate logistic regression analysis identified the following independent risk factors: age-adjusted Charlson Comorbidity Index (aCCI) score (odds ratio [OR] = 1.34, 95% confidence interval [CI] 1.04-1.72); preoperative nutritional risk assessed by Nutritional Risk Screening 2002 (NRS2002) (OR = 2.15, 95% CI 1.13-4.11); body mass index at admission (OR = 4.06, 95% CI 2.32-7.09); and body fat percentage 2 weeks postoperatively (OR = 6.07, 95% CI 2.73-13.49).
conclusionsThis study reveals the high incidence of postoperative sarcopenia in pancreatic cancer patients and identifies key influencing factors, which may help to improve clinical management and patient outcomes.
Indexed as
Identifiers
41258980What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.